We are deeply saddened by the loss of Dr. Bakris, whose dedication and contributions to CMHC as a renowned expert, educator, and mentor in the cardiorenal metabolic space have left an indelible mark on our community. In honor of his memory, we dedicated the 19th Annual Cardiometabolic Health Congress will celebrate his life and legacy. Click here to read more on Dr. Bakris and his legacy.
By registering for the 19th Annual CMHC On Demand, you are demonstrating your commitment to delivering evidence-based, whole-patient cardiometabolic care. If you attended the live meeting you will receive complimentary access to the recordings after the meeting via an email announcement. Please reach out to info@cardiometabolichealth.org if you have questions.
Conference Chairs
Senior Planning Committee
Conference faculty
AGENDA
FDA Update and Keynote
A Tribute to George L. Bakris, MD
FDA Update and Late Breaking Trials
Moderator: Christie M. Ballantyne, MD
Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Anne L. Peters, MD
KEYNOTE
Prevention and Treatment of Atherosclerosis
Peter Libby, MD
Session I: CardioRenal
Opening Remarks
Keith C. Ferdinand, MD
Current and Emerging Therapies for Resistant Hypertension
Keith C. Ferdinand, MD
Rajiv Agarwal, MD, MS
Overview of Cardiac Biomarkers for Cardiovascular Risk Stratification
Chiadi Ndumele, MD
Challenging Cardiorenal Cases & Panel Discussion & Audience Questions
Moderator: Keith C. Ferdinand, MD
Panelists: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Chiadi Ndumele, MD
Session II: Obesity
Opening Remarks
Robert H. Eckel, MD
Delving into Behavioral Approaches to Manage Obesity for Optimum Cardiometabolic Health
Sam Dagogo-Jack, MD, DSc, MBA
Ultra-Processed Food Addiction: Signs and Solutions
Erica M. LaFata, PhD
Advances in Obesity Pharmacotherapy
Louis J. Aronne, MD
Sleep Disorders and Cardiometabolic Health
Virend K. Somers, MD, PhD
Challenges in Surgical Approaches to Obesity: Patient Selection, Procedures, Weight Regain
Dimitrios Stefanidis, PhD, MD
Challenging Obesity Management Cases & Panel Discussion & Audience Questions
Moderator: Robert H. Eckel, MD
Panelists: Louis J. Aronne, MD; Sam Dagogo-Jack, MD, DSc, MBA; Erica M. LaFata, PhD; Dimitrios Stefanidis, PhD, MD; Virend K. Somers, MD, PhD
Session III: Diabetes
Robert H. Eckel, MD
Precision Medicine in Diabetes
Jose C. Florez, MD, PhD
Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients
Jay H. Shubrook, DO, FAAFP, FACOFP
CGM in People Without Diabetes and CVD Risk
Grazia Aleppo, MD, FACE, FACP
Grazia Aleppo, MD, FACE, FACP
Challenging Diabetes Management Cases & Panel Discussion & Audience Questions
Moderator: Robert H. Eckel, MD
Panelists: Grazia Aleppo, MD, FACE, FACP; Jose C. Florez, MD, PhD; Jay H. Shubrook, DO, FAAFP, FACOFP
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis
Opening Remarks
Christie M. Ballantyne, MD
LDL Lowering Therapy Beyond Statin
Supported by an educational grant from Esperion Therapeutics.
Pamela B. Morris, MD
How to Improve Cardiovascular Outcomes in Women
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC
Primary Prevention of CVD: The Sooner the Better?
Erin D. Michos, MD
Exploring Solutions for Severe Hypertriglyceridemia and FCS: Current Challenges and Progress
Supported by an educational grant from Arrowhead Pharmaceuticals.
Michael D. Shapiro, DO
Understanding Lipoprotein(a): Implications for Cardiovascular Risk and Management
Christie M. Ballantyne, MD
Challenging Lipid Management Cases & Panel Discussion & Audience Questions
Moderator: Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD; Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC; Erin D. Michos, MD; Pamela B. Morris, MD; Michael D. Shapiro, DO
Closing Remarks
Christie M. Ballantyne, MD
